Inhibitory effect of a lichen polysaccharide sulfate, GE-3-S, on the replication of human immunodeficiency virus (HIV) in vitro. 1989

K Hirabayashi, and S Iwata, and M Ito, and S Shigeta, and T Narui, and T Mori, and S Shibata

A sulfate (GE-3-S) prepared by chlorosulfonic acid treatment of GE-3, a partially acetylated beta(1----6) glucan of the lichen Umbilicaria esculenta, inhibited the cytopathic effect of human immunodeficiency virus (HIV) and suppressed the HIV-antigen expression in Molt-4 (clone 8) cells. GE-3-S also suppressed the giant cell formation of HIV-infected Molt-4 cells, and inhibited HIV-induced plaque formation by 50% at the dose of 19.5 micrograms/ml and completely at 250 micrograms/ml in MT4 cells. GE-3-S had no direct effect on the reverse transcriptase of HIV.

UI MeSH Term Description Entries
D011134 Polysaccharides Long chain polymeric CARBOHYDRATES composed of MONOSACCHARIDES linked by glycosidic bonds. Glycan,Glycans,Polysaccharide
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications

Related Publications

K Hirabayashi, and S Iwata, and M Ito, and S Shigeta, and T Narui, and T Mori, and S Shibata
July 1987, Antiviral research,
K Hirabayashi, and S Iwata, and M Ito, and S Shigeta, and T Narui, and T Mori, and S Shibata
August 1988, Proceedings of the National Academy of Sciences of the United States of America,
K Hirabayashi, and S Iwata, and M Ito, and S Shigeta, and T Narui, and T Mori, and S Shibata
February 1990, Biochemical and biophysical research communications,
K Hirabayashi, and S Iwata, and M Ito, and S Shigeta, and T Narui, and T Mori, and S Shibata
December 1988, Antiviral research,
K Hirabayashi, and S Iwata, and M Ito, and S Shigeta, and T Narui, and T Mori, and S Shibata
September 2000, The Journal of antibiotics,
K Hirabayashi, and S Iwata, and M Ito, and S Shigeta, and T Narui, and T Mori, and S Shibata
May 1994, The Journal of antibiotics,
K Hirabayashi, and S Iwata, and M Ito, and S Shigeta, and T Narui, and T Mori, and S Shibata
September 1993, Nihon rinsho. Japanese journal of clinical medicine,
K Hirabayashi, and S Iwata, and M Ito, and S Shigeta, and T Narui, and T Mori, and S Shibata
November 1988, The Journal of antibiotics,
K Hirabayashi, and S Iwata, and M Ito, and S Shigeta, and T Narui, and T Mori, and S Shibata
January 2001, Microbiology and immunology,
K Hirabayashi, and S Iwata, and M Ito, and S Shigeta, and T Narui, and T Mori, and S Shibata
February 1992, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!